54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 29
00:37 UTC
|
BKR
Baker Hughes
|
◎ Target | Stephen Gengaro ★★☆☆☆ #2556 | Buy | $74.00→ $75.00+1.4% |
|
Jul 29
00:37 UTC
|
BKR
Baker Hughes
|
◎ Target | Derek Podhaizer ★☆☆☆☆ #2942 | Overweight | $71.00→ $73.00+2.8% |
|
Jul 29
00:37 UTC
|
BKR
Baker Hughes
|
◎ Target | Josh Silverstein ★★☆☆☆ #2293 | Neutral | $73.00→ $71.00-2.7% |
|
Jul 29
00:37 UTC
|
BKR
Baker Hughes
|
◎ Target | Marc Bianchi ★☆☆☆☆ #3141 | Buy | $77.00→ $78.00+1.3% |
|
Jul 29
00:37 UTC
|
BKR
Baker Hughes
|
◎ Target | Charles Minervino ★★☆☆☆ #2412 | Positive | $70.00→ $72.00+2.9% |
|
Jul 29
00:37 UTC
|
BHR
BRAEMAR HOTELS & RESORTS
|
◎ Target | Michael Bellisario ★★★★★ #43 | Neutral | $2.00→ $2.50+25.0% |
|
Jul 29
00:37 UTC
|
BCAL
California BanCorp
|
◎ Target | Gary Tenner ★★★★★ #213 | Buy | $23.50→ $25.00+6.4% |
|
Jul 29
00:37 UTC
|
BBWI
Bath & Body Works
|
◎ Target | Sydney Wagner ★★★★★ #125 | Hold | $22.00→ $23.00+4.5% |
|
Jul 29
00:37 UTC
|
BBD.B
Bombardier, Inc. Class B
|
◎ Target | firm only | Hold | C$292.00→ C$306.00+4.8% |
|
Jul 29
00:37 UTC
|
BAX
Baxter International
|
◎ Target | Patrick Wood ★★★☆☆ #2159 | Neutral | $19.00→ $25.00+31.6% |
|
Jul 29
00:37 UTC
|
BAX
Baxter International
|
◎ Target | Rick Wise ★★★★★ #27 | Hold | $19.00→ $24.00+26.3% |
|
Jul 29
00:37 UTC
|
AZN
AstraZeneca
|
◎ Target | firm only | Buy | £175→ £178+1.7% |
|
Jul 29
00:37 UTC
|
AXTI
AXT
|
◎ Target | Dave Kang ★☆☆☆☆ #3134 | Neutral | $73.00→ $52.00-28.8% |
|
Jul 29
00:37 UTC
|
ATRC
AtriCure
|
◎ Target | Priya Sachdeva not yet tracked | Buy | $55.00→ $50.00-9.1% |
|
Jul 29
00:37 UTC
|
ARGX
argenex
|
◎ Target | David Nierengarten ★★☆☆☆ #2446 | Outperform | $1,000.00→ $1,050.00+5.0% |
|
Jul 29
00:37 UTC
|
APC
Anadarko Petroleum
|
◎ Target | Gabriel Moreen not yet tracked | Neutral | $20.00→ $22.00+10.0% |
|
Jul 29
00:37 UTC
|
AMZN
Amazon.com
|
◎ Target | Lloyd Walmsley ★★★☆☆ #2026 | Outperform | $325.00→ $320.00-1.5% |
|
Jul 29
00:37 UTC
|
AMR
Alpha Metallurgical Resources
|
◎ Target | Nick Giles ★☆☆☆☆ #3228 | Neutral | $194.00→ $189.00-2.6% |
|
Jul 29
00:37 UTC
|
AMKR
Amkor Technology
|
◎ Target | Joseph Moore ★★☆☆☆ #2558 | Equal Weight | $69.00→ $70.00+1.4% |
|
Jul 29
00:37 UTC
|
AMKR
Amkor Technology
|
◎ Target | Craig Ellis ★☆☆☆☆ #3130 | Neutral | $75.00→ $65.00-13.3% |
|
Jul 29
00:37 UTC
|
ALB
Albemarle
|
◎ Target | Ben Isaacson ★★★☆☆ #2177 | Sec→ r Outperform | $215.00→ $200.00-7.0% |
|
Jul 29
00:37 UTC
|
AJB
AJ Bell
|
◎ Target | firm only | Hold | GBX 560→ GBX 590+5.4% |
|
Jul 29
00:37 UTC
|
AGYS
Agilysys
|
◎ Target | Billy Fitzsimmons ★★★★★ #222 | Overweight | $110.00→ $120.00+9.1% |
|
Jul 29
00:37 UTC
|
AGYS
Agilysys
|
◎ Target | Mayank Tandon ★★★★☆ #415 | Buy | $120.00→ $130.00+8.3% |
|
Jul 29
00:37 UTC
|
ABT
Abbott Laboratories
|
◎ Target | Patrick Wood ★★★☆☆ #2159 | Buy | $135.00→ $125.00-7.4% |
|
Jul 29
00:37 UTC
|
ABCB
Ameris Bancorp
|
◎ Target | John McDonald not yet tracked | Hold | $92.00→ $90.00-2.2% |
|
Jul 29
00:37 UTC
|
XOM
ExxonMobil
|
↓ Downgrade | Jean Ann Salisbury ★★★★☆ #858 | Buy→ Neutral | $154.00→ $158.00+2.6% |
|
Jul 29
00:37 UTC
|
VC
Visteon
|
↓ Downgrade | Emmanuel Rosner ★☆☆☆☆ #2971 | Outperform→ Peer Perform | |
|
Jul 29
00:37 UTC
|
SYRE
Spyre Therapeutics
|
↓ Downgrade | Andy Chen ★★★☆☆ #1685 | Outperform→ Peer Perform | |
|
Jul 29
00:37 UTC
|
SIGI
Selective Insurance Group
|
↓ Downgrade | Michael Zaremski ★★★★★ #76 | Outperform→ Market Perform | $97.00 |
|
Jul 29
00:37 UTC
|
PYPL
PayPal
|
↓ Downgrade | Timothy Chiodo ★★★★★ #283 | Neutral→ Hold | |
|
Jul 29
00:37 UTC
|
PRCT
PROCEPT BioRobotics
|
↓ Downgrade | Danielle Antalffy ★★★☆☆ #1627 | Buy→ Neutral | $20.00 |
|
Jul 29
00:37 UTC
|
PODD
Insulet
|
↓ Downgrade | Patrick Wood ★★★☆☆ #2159 | Buy→ Neutral | $174.00 |
|
Jul 29
00:37 UTC
|
ISRG
Intuitive Surgical
|
↓ Downgrade | Mathew Blackman ★★★★☆ #598 | Buy→ Hold | |
|
Jul 29
00:37 UTC
|
INTU
Intuit
|
↓ Downgrade | Jared Levine ★★★★★ #88 | Buy→ Hold | $504.00→ $304.00-39.7% |
|
Jul 29
00:37 UTC
|
FMS
Fresenius Medical Care AG & Co. KGaA
|
↓ Downgrade | firm only | Neutral→ Underperform | $19.90 |
|
Jul 29
00:37 UTC
|
FBRX
Forte Biosciences
|
↓ Downgrade | Etzer Darout ★★★★☆ #954 | Overweight→ Equal Weight | $74.00→ $77.00+4.1% |
|
Jul 29
00:37 UTC
|
EBC
Eastern Bankshares
|
↓ Downgrade | Matt Breese not yet tracked | Overweight→ Equal Weight | $24.00 |
|
Jul 29
00:37 UTC
|
CLX
Clorox
|
↓ Downgrade | Kaumil Gajrawala ★★☆☆☆ #2821 | Buy→ Hold | $125.00→ $98.00-21.6% |
|
Jul 29
00:37 UTC
|
BMRC
Bank of Marin Bancorp
|
↓ Downgrade | firm only | Buy→ Neutral | $33.00 |
|
Jul 29
00:37 UTC
|
WOSG
Watches of Switzerland Group
|
↑ Upgrade | firm only | Sec→ r perform | GBX 725→ GBX 800+10.3% |
|
Jul 29
00:37 UTC
|
WEGZY
WEG
|
↑ Upgrade | firm only | Sell→ Neutral | |
|
Jul 29
00:37 UTC
|
TRU
TransUnion
|
↑ Upgrade | firm only | Neutral→ Outperform | |
|
Jul 29
00:37 UTC
|
SOLV
Solventum
|
↑ Upgrade | Kevin Caliendo ★★★★☆ #424 | Neutral→ Buy | $95.00 |
|
Jul 29
00:37 UTC
|
RELL
Richardson Electronics
|
↑ Upgrade | Bobby Brooks ★★★☆☆ #2163 | Market Perform→ Outperform | $14.00→ $24.00+71.4% |
|
Jul 29
00:37 UTC
|
PYPL
PayPal
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Jul 29
00:37 UTC
|
NTR
Nutrien
|
↑ Upgrade | firm only | Neutral→ Outperform | $80.00 |
|
Jul 29
00:37 UTC
|
MGY
Magnolia Oil & Gas
|
↑ Upgrade | Gabe Daoud not yet tracked | Hold→ Buy | $32.00→ $33.00+3.1% |
|
Jul 29
00:37 UTC
|
MDT
Medtronic
|
↑ Upgrade | Priya Sachdeva not yet tracked | Neutral→ Buy | $85.00→ $100.00+17.6% |
|
Jul 29
00:37 UTC
|
LU
Lufax
|
↑ Upgrade | Katherine Lei ★★★★★ #323 | Neutral→ Overweight | $2.00 |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.